November 06, 2024 at 1:54 pm

Stocks making the biggest moves midday: Super Micro Computer, Tesla, Coinbase, Planet Fitness and more

Here are the midday trading updates that you should not miss today. Trump Media and Technology Group.-associated shares — Stocks connected to Donald Trump’s election skyrocketed as his return to the White House became certain. Trump’s own business, Trump Media & Technology, rose almost 5%, while Tesla, whose CEO openly supports the President-elect, leapt over… [Read More]
November 06, 2024 at 12:42 pm

Wheelin and Dealin: Cerence and Kawasaki Partner to Provide AI Assistance to Riders

The AI mobility experience leader Cerence, Inc. (CRNC) has announced a partnership with Kawasaki Motors to enhance user experience across its two-wheeled vehicles. Kawasaki intends to integrate Cerence Ride into its two wheelers which will provide users with information that can help navigate, control the vehicle and provide cloud applications through an voice-activated AI assistant…. [Read More]
November 06, 2024 at 11:38 am

Acadia Pharmaceuticals Sells Rare Pediatric Priority Review Voucher for $150M to Fuel CNS and Rare Disease R&D

Acadia Pharmaceuticals (Nasdaq: ACAD) has announced an agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $150 million. The PRV was awarded to Acadia in March 2023 after the FDA approved DAYBUE™ (trofinetide) for treating Rett syndrome, a therapy licensed from Neuren Pharmaceuticals. Per their agreement, Acadia will pay Neuren one-third of… [Read More]
November 06, 2024 at 11:01 am

PRISM NextGen Tech and AI: Spectral AI Plans to Spin Off Subsidiary Spectral IP

A leading artificial intelligence (AI) company specializing in medical diagnostics to support faster and more precise treatment decisions in wound care, Spectral AI, Inc. (MDAI) has announced plans to spin off its subsidiary, Spectral IP, Inc. through a transaction with Sauvegarder Investment Management, Inc., a development-stage company focused on financing and monetizing intellectual property (IP)… [Read More]
November 06, 2024 at 10:45 am

PRISM Top Takeaways from the Think Equity Conference: Game-Changing Innovators Reshaping Industries

Innovation sets leading public companies apart in competitive markets. By introducing breakthrough products and disruptive approaches, innovative companies carve out unique positions and set trends. This differentiation helps them build resilience, attract loyal customers, capture market share and provide shareholder value. Last week, PRISM MarketView attended the Think Equity conference held at the Mandarin Oriental… [Read More]
November 06, 2024 at 9:00 am

Stocks making the biggest moves premarket: Tesla, DJT, CVS Health, Dollar Tree and more

Dive into the headlines surrounding top companies as the stock market prepares to open. Crypto stocks – A more favorable regulatory environment for cryptocurrency businesses under a potential second Trump presidency sent shares of Coinbase soaring by 12%. Additionally, MicroStrategy, a company that’s performance is closely tied to the bitcoin price, saw an increase of… [Read More]
November 05, 2024 at 3:43 pm

Despite Its “Mustard Only” Tradition, Chicago-based Hotdog Slinger Portillo’s Needs to ‘Ketchup’ On Revenues

The fast casual restaurant owner and operator, Portillo’s Inc. (PTLO) who is known for its Chicago favorite foods that include hotdogs and Italian beef sandwiches, announced Q3 financials that posted EPS of $0.11 vs FactSet $0.06 but missed on revenues citing $178.3M vs FactSet 182.1M. Despite revenues increasing by 6.9% from the prior year, shares… [Read More]
November 05, 2024 at 11:16 am

Quoin Initiates First Clinical Testing of Lead Product on Pediatric Netherton Syndrome Patient

Quoin Pharmaceuticals (Nasdaq:QNRX) has initiated clinical testing of its lead product, QRX003, in a pediatric patient with Netherton Syndrome (NS) at Children’s Health Ireland. This trial marks the first time QRX003 is being evaluated in a young child, representing a significant step in expanding the patient base and data for this potential treatment. A second… [Read More]
November 05, 2024 at 10:50 am

ZyVersa Therapeutics Unveils Positive Data Showing Potential to Protect Pancreatic Cells and Slow Progression from Obesity to Type 2 Diabetes, Shares Rise 41%

ZyVersa Therapeutics (NASDAQ: ZVSA) announced positive data highlighting the potential of its inflammasome inhibitor, IC 100, in preserving pancreatic islet beta cells and reducing inflammation-related damage that contributes to insulin resistance and type 2 diabetes. Published research showed that inhibiting the inflammasome NLRP3 pathway in an obesity model helped protect and restore beta cell function,… [Read More]